Neuroelectrics — Series A · $17.5M

Barcelona-founded neuromodulation company (also based in Cambridge, MA) raised a $17.5M Series A led by Morningside to run clinical trials of its Starstim non-invasive brain stimulation platform. The trials target refractory epilepsy and at-home treatment of depression.

LeadMorningside Ventures RoundSeries A Announced4 May 2021 CityBarcelona SectorHealthtech & Bio · Healthtech / Neurotech Source B

Something wrong? Suggest a correction →